SCHEMBL4795196

SCHEMBL4795196

OCCCCCCCCCCCC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10711626 1.00 THRB (0.30) THRB
SCHEMBL4867921 1.00 THRB (0.30) THRB
SCHEMBL10709471 1.00 THRB (0.30) THRB
SCHEMBL1025782 1.00 THRB (0.30) THRB
SCHEMBL5570616 1.00 THRB (0.30) THRB
SCHEMBL10711465 1.00 THRB (0.30) THRB
SCHEMBL10554776 1.00 THRB (0.30) THRB
SCHEMBL10711229 1.00 THRB (0.30) THRB
SCHEMBL10709739 1.00 THRB (0.30) THRB
SCHEMBL10710141 1.00 THRB (0.30) THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1509536-B1 FLUORINATED PHOSPHONIC ACIDS 3M INNOVATIVE PROPERTIES CO (US) 2008-08-13 EP disclosed
WO-2008060931-A2 METHOD FOR PREPARING FLUORINATED BENZOTRIAZOLE COMPOUNDS 3M INNOVATIVE PROPERTIES COMPANY (US) 2008-05-22 WO disclosed
US-20080114177-A1 METHOD FOR PREPARING FLUORINATED BENZOTRIAZOLE COMPOUNDS 3M INNOVATIVE PROPERTIES COMPANY 2008-05-15 US disclosed
EP-1509536-A1 FLUORINATED PHOSPHONIC ACIDS 3M Innovative Properties Company (US) 2005-03-02 EP disclosed
US-6824882-B2 WATERPROOFING, CORROSION RESISTANCE PROTECTIVE COATINGS 3M INNOVATIVE PROPERTIES COMPANY 2004-11-30 US disclosed
WO-2003102003-A1 FLUORINATED PHOSPHONIC ACIDS 3M INNOVATIVE PROPERTIES COMPANY (US) 2003-12-11 WO disclosed
US-20030228469-A1 Fluorinated phosphonic acids 3M INNOVATIVE PROPERTIES COMPANY 2003-12-11 US disclosed
US-5939370-A ETHERIFICATION WITH FLUOROALKYL COMPOUND AND BASIFICATION OR ACIDIFICATION TO FORM ACID OR SALT CECA S.A. (FR) 1999-08-17 US disclosed
EP-0819698-A2 Fluoroalkyl uronic acid glycosides and the corresponding 6(3)-lactones, preparation and use CECA S.A. (FR) 1998-01-21 EP disclosed
US-4889953-A ANTITUMOR AND -CARCINOGENIC AGENTS; PLATELET ACTIVATING FACTOR ANTAGONIST; CARDIOVASCULAR DISORDERS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1989-12-26 US disclosed
EP-0138095-B1 METHOD OF ALKOXYLATING FLUORINATED ALCOHOLS E.I. DU PONT DE NEMOURS AND COMPANY (US) 1988-07-27 EP disclosed
EP-0161459-B1 ALCOHOL-AMINE ALKOXYLATES Conoco Phillips Company (US) 1988-05-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080114177-A1 METHOD FOR PREPARING FLUORINATED BENZOTRIAZOLE COMPOUNDS CYP2E1, FLI1, GABBR1 THRB 2069/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.